The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer

Clinical trial NCT04694183 · COMPLETED

Trial details

NCT number: NCT04694183
Sponsor: Quan Wang
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stomach Neoplasms

Start date: 2020-08-17
Primary completion: 2023-05-06
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.